Dr James Ritchie

Dr James Ritchie

Contact details:



MB ChB:  University of Sheffield, 2004

MRCP (UK): Royal College of Physicians, 2014

PhD Med: University of Manchester, 2014

Present appointments:

  • Consultant Renal Physician, Northern Care Alliance NHS Foundation Trust: 2015 – present
  • Honorary Clinical Lecturer, University of Manchester: 2016 – present
  • Chief Clinical Information Officer, Northern Care Alliance NHS Foundation Trust: 2018 – present
  • Deputy Director for Research and Innovation (Digital & Artificial Intelligence): 2020 – present
  • Co-Chair Clinical and Operational Group, Health Innovation Manchester: 2022 – present

Previous appointments:

  • Program Director – Digital Control Centre, Salford Royal Foundation Trust: 2017 – 2020

Research interests/expertise:

  • Digital health and technologies

Current research grants:

  • Revolutionising Outpatient Clinic Experience – CKD (RevOCE-CKD), Astra Zeneca Joint Working Agreement (2020 – ongoing).
  • Catalyst grant co-applicant (Using Artificial Intelligence and Data Analysis to Better Detect Cardiovascular Disease), British Heart Foundation, (2022 – ongoing)

Publications (last 5 years):


Storrar J, Gill-Taylor T, Chinnadurai R, Chrysochou C, Poulikakos D, Rainone F, Ritchie J, Lamerton E, Kalra PA, Sinha S. A low rate of end-stage kidney disease in membranous nephropathy: A single centre study over 2 decades. PLoS One 2022 Oct 13;17(10):e0276053.

Hamilton P, Kanigicherla D, Hanumapura P, Blaikie K, Ritchie J, Sinha S, Brenchley P, Mitra S. Peptide GAM immunoadsorption in anti-PLA2 R positive autoimmune membranous nephropathy. The PRISM trial. J. Clin. Apher. 2022 Feb;37(1):40-53.


Alderson HV, Chinnadurai R, Ibrahim ST, Asar O, Ritchie JP, Middleton R, Larsson A, Diggle PJ, Larsson TE, Kalra PA. Longitudinal change in c-terminal fibroblast growth factor 23 and outcomes in patients with advanced chronic kidney disease. BMC Nephrol. 2021 Oct 2;22(1):329.


Lodge MDS, Abeygunaratne T, Alderson H, Ali I, Brown N, Chrysochou C, Donne R, Erekosima I, Evans P, Flanagan E, Gray S, Green D, Hegarty J, Hyde A, Kalra PA, Lamerton E, Lewis D, Middleton R, New D, Nipah R, O’Donoghue D, O’Riordan E, Poulikakos D, Rainone F, Raman M, Ritchie J, Sinha S, Wood G, Tollitt J. Safely reducing haemodialysis frequency during the COVID-19 pandemic. BMC Nephrol. 2020 Dec 7;21(1):532.

Fenton A, Chinnadurai R, Gullapudi L, Kampanis P, Dasgupta I, Ritchie J, Harding S, Ferro CJ, Kalra PA, Taal MW, Cockwell P. Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: A cohort study. PLoS Med. 2020 Feb 28;17(2):e1003050.


Vassallo D, Alderson H, Vuilleumier N, Ritchie J, Green D, Pagano S, Virzi J, Chrysochou C, Kalra PA. Association of novel biomarkers with major clinical outcomes in a cohort of patients with atherosclerotic renovascular disease. Ann. Clin. Biochem. 2019 Jul;56(4):488-501.

Sykes L, Asar O, Ritchie J, Raman M, Vassallo D, Alderson HV, O’Donoghue DJ, Green D, Diggle PJ, Kalra PA. The influence of multiple episodes of acute kidney injury on survival and progression to end stage kidney disease in patients with chronic kidney disease. PLoS One. 2019 Jul 18;14(7):e0219828.

Tollitt J, Bennett N, Darby D, Flanagan E, Chadwick P, Sinha S, Kalra PA, Ritchie J, Poulikakos D. The importance of acute kidney injury in suspected community acquired infection. PLoS One. 2019 May 7;14(5):e0216412.

Chinnadurai R, Ritchie J, Green D, Kalra PA. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease. Nephrol. Dial. Transplant. 2019 Mar 1;34(3):449-457.


Tollitt J, Flanagan E, McCorkindale S, Glynn-Atkins S, Emmett L, Darby D, Ritchie J, Bennett B, Sinha S, Poulikakos D. Improved management of acute kidney injury in primary care using e-alerts and an educational outreach programme. Fam. Pract. 2018 Dec 12;35(6):684 – 689.

Green D, Ritchie JP, Chrysochou C, Kalra PA. Revascularization of atherosclerotic renal artery stenosis for chronic heart failure versus acute pulmonary oedema. Nephrology (Carlton). 2018 May;23(5):411-417.

Vassallo D, Ritchie J, Green D, Chrysochou C, Kalra PA. The effect of revascularization in patients with anatomically significant atherosclerotic renovascular disease presenting with high-risk clinical features. Nephrol Dial Transplant. 2018 Mar 1;33(3):497-506.

Greenan K, Vassallo D, Chinnadurai R, Ritchie J, Shepherd K, Green D, Ponnusamy A, Sinha S. Respiratory manifestations of ANCA-associated vasculitis. Clin. Respir J. 2018 Jan;12(1):57-61.

Skip to content